Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Large Increase in Short Interest

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANLGet Free Report) was the recipient of a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 757,655 shares, an increase of 458.7% from the January 15th total of 135,611 shares. Currently, 2.1% of the company’s shares are sold short. Based on an average daily trading volume, of 1,844,236 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily trading volume, of 1,844,236 shares, the days-to-cover ratio is presently 0.4 days. Currently, 2.1% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a research report on Wednesday, January 21st. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Reduce”.

View Our Latest Stock Analysis on Adlai Nortye

Adlai Nortye Trading Up 3.9%

Shares of ANL opened at $9.65 on Friday. The firm has a fifty day simple moving average of $3.42 and a two-hundred day simple moving average of $2.24. Adlai Nortye has a 1-year low of $0.88 and a 1-year high of $12.09.

About Adlai Nortye

(Get Free Report)

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.

Further Reading

Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.